Optimal Treatment for the High-Risk Salivary Gland Cancer
Jeong-Soo Woo
Clin Exp Otorhinolaryngol. 2020;13(1):6-7.   Published online 2020 Feb 1     DOI: https://doi.org/10.21053/ceo.2019.01907
Citations to this article as recorded by Crossref logo
Disease and toxicity outcomes for a modern cohort of patients with squamous cell carcinoma of cutaneous origin involving the parotid gland: Comparison of volumetric modulated arc therapy and pencil beam scanning proton therapy
Reza Zarinshenas, Peter Campbell, Kai Sun, Jason K. Molitoris, Akshar N. Patel, Matthew E. Witek, Kevin J. Cullen, Ranee Mehra, Kyle M. Hatten, Kelly F. Moyer, Rodney J. Taylor, Kalpesh T. Vakharia, Jeffrey S. Wolf, Matthew J. Ferris
Radiotherapy and Oncology.2024; 193: 110112.     CrossRef
Parotid lymph nodes in primary malignant salivary neoplasms
Patrick J. Bradley
Current Opinion in Otolaryngology & Head & Neck Surgery.2022; 30(2): 99.     CrossRef
In reference to “Surgical treatment of the neck in patients with salivary gland carcinoma”
Suresh Mani, Subagar Anbarasan, Chirom Amit Singh, Rajeev Kumar
Head & Neck.2021; 43(11): 3697.     CrossRef